Register entry
- Registered sites
- 0
- Active NDC listings
- 5
- Live patents
- 33
- Countries
- 0
Catalogue
Drug listings by form and route
55 active NDC listings: 5 human prescription drug. By marketing category: NDA 5.
| Dosage form | NDCs |
|---|---|
| injection | 2 |
| for suspension | 1 |
| injection, powder, for solution | 1 |
| kit | 1 |
| Route | NDCs |
|---|---|
| intravenous | 3 |
| oral | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| la jolla pharmaceutical company | 5 |
Exclusivity
Patents and exclusivities
33| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10335451 | GIAPREZAangiotensin ii acetate | use | Dec 2029 |
| 10500247 | GIAPREZAangiotensin ii acetate | use | Dec 2029 |
| 10548943 | GIAPREZAangiotensin ii acetate | use | Dec 2029 |
| 9867863 | GIAPREZAangiotensin ii acetate | use | Dec 2029 |
| 9572856 | GIAPREZAangiotensin ii acetate | use | Nov 2030 |
| 10028995 | GIAPREZAangiotensin ii acetate | use | Dec 2034 |
| 10493124 | GIAPREZAangiotensin ii acetate | use | Dec 2034 |
| 11096983 | GIAPREZAangiotensin ii acetate | use | Dec 2034 |
| 11559559 | GIAPREZAangiotensin ii acetate | use | Dec 2034 |
| 9220745 | GIAPREZAangiotensin ii acetate | use | Dec 2034 |
| 11219662 | GIAPREZAangiotensin ii acetate | use | Jan 2037 |
Catalogue
Marketed products
5| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Giapreza | angiotensin II | injection, intravenous | 68547-005NDA |
| Giapreza | angiotensin II | injection, intravenous | 68547-501NDA |
| NUZOLVENCE | zoliflodacin | for suspension, oral | 68547-915NDA |
| Xacduro | sulbactam and durlobactam | kit | 68547-111NDA |
| ZEVTERA | ceftobiprole medocaril sodium | injection, powder, for solution, intravenous | 68547-578NDA |
Enquiry
Common questions
- Is La Jolla Pharmaceutical Company FDA approved?
- La Jolla Pharmaceutical Company holds no registered establishment of its own; 5 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does La Jolla Pharmaceutical Company make?
- 5 products are listed under La Jolla Pharmaceutical Company in the openFDA NDC Directory, most often as injection; for suspension; injection, powder, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.